Latest 10-Q quarterly reports
NASDAQ
HireQuest, Inc. reported a decrease in total revenue for Q1 2026 compared to the prior year, but saw an increase in net income, driven by a gain on divestiture and reduced operating expenses.
NASDAQ
Odyssey Marine Exploration reports on its Q1 2026 financial performance, a significant merger agreement with American Ocean Minerals, progress in its NAFTA arbitration against Mexico, and updates on its deep-sea mineral exploration projects.
OID
Ocean Thermal Energy Corporation reports significant revenue increase driven by a key defense contract, but faces ongoing liquidity challenges and substantial debt defaults.
NASDAQ
Hashdex Nasdaq CME Crypto Index ETF reports a decrease in net assets for Q1 2026, primarily due to market performance of underlying crypto assets.
NASDAQ
Corbus Pharmaceuticals reported a wider net loss for Q1 2026 due to increased R&D spending on its oncology and obesity drug candidates, while cash reserves remain sufficient for at least twelve months.
NASDAQ
Hennessy Capital Investment Corp. VIII reports on its Q1 2026 activities, including its initial public offering and ongoing search for a business combination.
NASDAQ
Insight Digital Partners II reports net income of $1.26 million for Q1 2026, driven by interest income from its trust account, while continuing its search for a business combination.
AMEX
Southland Holdings reported a significant increase in net loss for the first quarter of 2026, driven by a substantial revenue decrease primarily in its Transportation segment and increased gross losses.
NASDAQ
The Beachbody Company, Inc. reported a significant turnaround in its first quarter of 2026, achieving net income of $2.3 million after a substantial loss in the prior year, driven by reduced operating expenses and improved gross margins.
NASDAQ
Atea Pharmaceuticals, Inc. reported its first-quarter 2026 financial results, highlighting progress in its Hepatitis C (HCV) and Hepatitis E (HEV) development programs, with cash reserves expected to fund operations through 2027.
NASDAQ
NPCE
Neuropace INCNeuroPace reported a slight revenue decrease in Q1 2026 compared to the prior year, primarily due to the termination of a distribution agreement, but saw a significant improvement in gross margin.
Star Equity Holdings, Inc. reported a 57.1% increase in revenue for the first quarter of 2026, reaching $50.1 million, primarily driven by the acquisition of Star Operating Companies.
NYSE
Infinity Natural Resources, Inc. reported a significant increase in revenues for Q1 2026, driven by higher production volumes and the Antero Acquisition, despite a net loss.
AMEX
Impact BioMedical reports a net loss of $2.28 million for Q1 2026, a significant increase from the prior year, primarily due to substantial stock-based compensation expenses.
NASDAQ
EML
Eastern COThe Eastern Company reported a significant decrease in net income and sales for the first quarter of 2026 compared to the prior year, impacted by lower order volumes and increased tariff costs.
NASDAQ
FINW
Finwise BancorpFinWise Bancorp reported a decrease in net income for Q1 2026 compared to Q1 2025, primarily due to higher provisions for credit losses, despite significant growth in its Banking-as-a-Service segment.
NASDAQ
UPXI
Upexi, INCUpexi, Inc. reports significant shift to digital assets, with substantial unrealized losses and increased digital asset revenue, while traditional product revenue declines.
NASDAQ
Inhibikase Therapeutics reports increased R&D spending and SG&A costs in Q1 2026, with cash reserves sufficient for at least 12 months.
NYSE
Amentum Holdings, Inc. reported a significant increase in net income for the second quarter of fiscal year 2026, driven by improved operating income and a lower effective tax rate.
NASDAQ
Richmond Mutual Bancorporation reported a 41.5% increase in net income for the first quarter of 2026, driven by higher net interest income and improved non-interest income.
NASDAQ
Bank of the James Financial Group reports a significant increase in net income for Q1 2026, driven by higher net interest income, robust noninterest income, and reduced expenses.
NYSE
USANA Health Sciences reported a 0.3% increase in net sales to $250.2 million for Q1 2026, but net earnings attributable to USANA decreased by 20.1% to $7.5 million, impacted by lower operating margins and a higher tax rate.
OTC.Pink
VREOF
Vireo Growth INCVireo Growth Inc. reported a significant revenue increase of 333% to $106.2 million in Q1 2026, driven by strategic acquisitions and expanded operations.
OQB
Grown Rogue International Inc. reported a net loss of $2.21 million for Q1 2026, a significant shift from a net income of $742,870 in the prior year, driven by increased operating expenses and unrealized losses on financial instruments.
NASDAQ
SANUWAVE Health reports a 3% revenue increase to $9.6 million and a reduced net loss of $1.4 million for the first quarter of 2026, driven by higher disposable sales and a favorable year-over-year comparison.
NASDAQ
LB Pharmaceuticals Inc. announced its first-quarter 2026 financial results, highlighting progress in its clinical development programs for LB-102 and a strong cash position.
NASDAQ
First Capital, Inc. reported a significant increase in net income for the first quarter of 2026, driven by higher net interest income and growth in its loan portfolio.
NYSE
Rithm Acquisition Corp. reports net income of $2.02 million for Q2 2026, driven by interest income, while continuing its search for a business combination.
NASDAQ
Crane Harbor Acquisition Corp. II reports Q1 2026 results, with net income driven by trust account interest and ongoing efforts to identify a business combination.
OQX
JUSHF
Jushi Holdings INCJushi Holdings Inc. reported a 4% increase in net revenue for Q1 2026, driven by retail and wholesale growth, alongside a significant debt refinancing.